Chen X, Song E (2019) Turning foes to friends targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18:99–115

Article  CAS  PubMed  Google Scholar 

Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD (2014) Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl 8:454–463

Article  CAS  PubMed  Google Scholar 

Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E (2020) In search of definitions: Cancer-associated fibroblasts and their markers. Int J Cancer 146:895–905

Article  CAS  PubMed  Google Scholar 

Garin-Chesa P, Old LJ, Rettig WJ (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. P Natl Acad Sci U S A 87:7235–7239

Article  CAS  Google Scholar 

Zboralski D, Hoehne A, Bredenbeck A, Schumann A, Nguyen M, Schneider E et al (2022) Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. Eur J Nucl Med Mol I(49):3651–3667

Article  Google Scholar 

Jansen K, Heirbaut L, Verkerk R, Cheng JD, Joossens J, Cos P et al (2014) Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl) glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). J Med Chem 57:3053–3074

Article  CAS  PubMed  Google Scholar 

Edosada CY, Quan C, Tran T, Pham V, Wiesmann C, Fairbrother W et al (2006) Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity. FEBS Lett 580:1581–1586

Article  CAS  PubMed  Google Scholar 

Lai C, Cao R, Li R, He C, Wang X, Shi H et al (2023) Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma. Mol Pharm 20:4120–4128

Article  CAS  PubMed  Google Scholar 

Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus JU (2018) Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med 59:1415–1422

Article  CAS  PubMed  Google Scholar 

Loktev A, Lindner T, Mier W, Debus JU, Altmann A, Ager DJ (2018) A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med 59:1423–1429

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U (2023) FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease. Radiology 306:e220749

Article  PubMed  Google Scholar 

Lin J, Chuang C, Lin J, Huang F, Huang C (2021) Rational Design, Pharmacomodulation, and Synthesis of [68Ga]Ga-Alb-FAPtp-01, a Selective Tumor-Associated Fibroblast Activation Protein Tracer for PET Imaging of Glioma. ACS Sens 6:3424–3435

Article  CAS  PubMed  Google Scholar 

Kelly JM, Jeitner TM, Ponnala S Jr, CW, Nikolopoulou A, DiMagno SG et al (2021) A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα). Mol Imaging Biol 23:686–696

Article  CAS  PubMed  Google Scholar 

Zhang P, Xu M, Ding J, Chen J, Zhang T, Huo L et al (2022) Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy. Eur J Nucl Med Mol I(49):1985–1996

Article  Google Scholar 

Hu K, Li J, Wang L, Huang Y, Li L, Ye S et al (2022) Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts. Acta Pharm Sin B 12:867–875

Article  CAS  PubMed  Google Scholar 

Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Naka S, Ooe K et al (2022) Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. Eur J Nucl Med Mol I(49):871–880

Article  Google Scholar 

Watabe T, Liu Y, Kaneda-Nakashima K, Shirakami Y, Lindner T, Ooe K et al (2020) Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models. J Nucl Med 61:563–569

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei Y, Zheng J, Ma L, Liu X, Xu S, Wang S et al (2022) [18F] AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET/CT imaging of various cancers. Eur J Nucl Med Mol I(49):2761–2773

Article  Google Scholar 

Wang P, Wang S, Liu F, Ren Y, Guo Q, Zhang Q (2023) Preclinical Evaluation of a Fibroblast Activation Protein and a Prostate-Specific Membrane Antigen Dual-Targeted Probe for Noninvasive Prostate Cancer Imaging. Mol Pharmaceut 20:1415–1425

Article  CAS  Google Scholar 

Shi M, Yu D, Chen Y, Zhao C, Zhang J, Liu Q (2012) Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroentero 18:840–846

Article  CAS  Google Scholar 

Muliaditan T, Caron J, Okesola M, Opzoomer JW, Kosti P, Georgouli M et al (2018) Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis. Nat Commun 9:2951

Article  PubMed  PubMed Central  Google Scholar 

Croft AP, Campos J, Jansen K, Turner JD, Marshall J, Attar M et al (2019) Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570:246–251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu X, Khalil H, Kanisicak O, Boyer JG, Vagnozzi RJ, Maliken BD et al (2018) Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Invest 128:2127–2143

Article  PubMed  PubMed Central  Google Scholar 

Egger C, Cannet C, Gérard C, Suply T, Ksiazek I, Jarman E et al (2017) Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol 809:64–72

Article  CAS  PubMed  Google Scholar 

Ma Y, Iyer RP, Jung M, Czubryt MP, Lindsey ML (2017) Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps. Trends Pharmacol Sci 38:448–458

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenkrans ZT, Massey CF, Bernau K, Ferreira CA, Jeffery JJ, Schulte JJ et al (2022) [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity. Eur J Nucl Med Mol I(49):3705–3716

Article  Google Scholar 

Varasteh Z, Mohanta S, Robu S, Braeuer M, Li Y, Omidvari N et al (2019) Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04. J Nucl Med 60:1743–1749

Article  CAS  PubMed  PubMed Central  Google Scholar